Notice of Refund | Oct 21, 2019 | PAPER | BOARD |
PETITIONER NALOX-1 PHARMACEUTICALS, LLC¿¿¿S REQUEST FOR REFUND OF POST-INSTITUTION FEES | Oct 3, 2019 | PAPER | PETITIONER |
Denying Institution of Inter Partes Review
35 U.S.C. sec. 314(a) | Aug 27, 2019 | PAPER | BOARD |
PATENT OWNER'S NOTICE OF TRIAL DATE IN THE TEVA CASE | Jul 22, 2019 | PAPER | PATENT OWNER |
PATENT OWNER'S RESPONSE TO PETITIONER'S NOTICE | Jun 24, 2019 | PAPER | PATENT OWNER |
Petitioner's Notice of Rankings | Jun 17, 2019 | PAPER | PETITIONER |
Conduct of the Proceeding | Jun 11, 2019 | PAPER | BOARD |
Opiant2001 Williams Decl | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2003 Aquina 2009 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2004 Baca 2005 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2005 Belz 2006 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2006 Buajordet 2004 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2002 Amphastar Press Release | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2009 FDA Teva Press Release | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2011 Goldfranks | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2012 Indivior Press Release | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2015 Loimer 1992 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2017 Osterwalder 1996 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2018 Pallasch 1981 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2019 Popper 1989 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2025 Teva Case Claim Construction Opinion | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2007 Burford Press Release | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2008 EVZIO Prescribing Information | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2010 Gaddis 1992 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2013 Kelly 2002 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2014 Letter from Ten Congressmen | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2016 Narcan Nasal Spray Prescribing Information | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2020 Schwartz 1987 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2021 Sporer 1996 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2022 Sporer 2007 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2023 Stoove 2009 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2024 Terman 2012 Slides | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2026 Teva Case Schedule Stipulation | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2027 van Dorp 2007 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2028 Walley 2013 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2029 Wermeling 2015 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2030 Wermeling 354 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2031 Williams 2019 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2032 Yealy 1990 | May 28, 2019 | EXHIBIT | PATENT OWNER |
Opiant2033 Zuckerman 2014 | May 28, 2019 | EXHIBIT | PATENT OWNER |
PRELIMINARY RESPONSE OF PATENT OWNER OPIANT PHARMACEUTICALS, INC. | May 28, 2019 | PAPER | PATENT OWNER |
MANDATORY NOTICES OF PATENT OWNER OPIANT PHARMACEUTICALS, INC. | Mar 12, 2019 | PAPER | PATENT OWNER |
POWER OF ATTORNEY FOR OPIANT PHARMACEUTICALS, INC. | Mar 12, 2019 | PAPER | PATENT OWNER |
NOTICE OF FILING DATE ACCORDED TO PETITION
AND
TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE | Feb 25, 2019 | PAPER | BOARD |
Petition | Feb 19, 2019 | PAPER | PETITIONER |
Power of Attorney | Feb 19, 2019 | PAPER | PETITIONER |
Nalox1002 Donovan Declaration | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1003 Hochhaus Declaration | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1004 FH 15_183,441 Excerpt - Aug. 22, 2016 Action | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1008 Chinese Patent No. 1,575,795 (Wang) (Paginated Translation) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1009 WO 00_62,757 (Davies) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1012 Handbook of Pharmaceutical Excipients, selected pages | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1017 Alabama EMS Protocols (2013) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1019 Ashton | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1020 Barton (2002) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1021 Barton (2005) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1022 Bitter | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1024 CDC - Zomig Review | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1001 U. S. Patent 9,211,253 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1005 FH 15_183,441 Excerpt - Oct. 21, 2016 Resp. | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1007 U.S. Patent No. 9,192,570 (Wyse) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1010 Djupesland (2013) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1011 Grassin-Delyle (2012) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1013 Kushwaha (2011) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1014 U.S. Patent No. 5,866,154 (Bahal) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1015 U.S. Patent No. 8,198,291 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1016 Wermeling (2013) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1018 APTAR Press Release | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1023 Boyer | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1025 Commonwealth Kentucky Patient Care Protocols (2015) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1029 2003 FDA Guidance | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1032 Hertz Presentation | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1034 Kelly | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1035 Kerr (2008) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1036 Kerr (2009) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1039 Merck Index (47-60) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1026 Costantino | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1027 Dowling | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1028 2002 FDA Guidance | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1030 Freise | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1031 Glende | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1037 Kleiman-Wexler | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1038 Marple | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1041 Middleton | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1042 Monitto | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1044 PDR (2003) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1048 Role of Naloxone (76 Fed Reg. 71,348) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1050 Rosanske | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1053 Trows | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1054 USP 36-NF 31 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1055 U.S. Patent Appl. No. 61_918,802 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1056 U.S. Patent No. 5,307,953 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1057 U.S. Patent No. 5,813,570 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1059 Wermeling (2010) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1060 Loimer | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1061 Doe-Simkins | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1040 Merlin | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1043 Lemke | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1045 PDR (2010) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1046 Robertson (2005) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1047 Robertson (2009) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1049 Role of Naloxone (Full Transcript), 2012.04.12 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1051 Sabzghabaee | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1058 U.S. Provisional Patent App. 61_953379 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1062 McDermott | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1064 Butler | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1065 Wisconsin - part 2 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1065 Wisconsin - part 1 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1066 Lipscomb | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1006 FH 15_183,441 Excerpt - Dec. 21, 2016 NOA | Feb 19, 2019 | EXHIBIT | PETITIONER |